Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma.
about
Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Targeting the extradomain A of ...... herapy in experimental glioma.
@en
Targeting the extradomain A of ...... herapy in experimental glioma.
@nl
type
label
Targeting the extradomain A of ...... herapy in experimental glioma.
@en
Targeting the extradomain A of ...... herapy in experimental glioma.
@nl
prefLabel
Targeting the extradomain A of ...... herapy in experimental glioma.
@en
Targeting the extradomain A of ...... herapy in experimental glioma.
@nl
P2093
P2860
P356
P1433
P1476
Targeting the extradomain A of ...... herapy in experimental glioma.
@en
P2093
Alessandro Palumbo
Anna Lena Datwyler
Christoph Harms
Dario Neri
Eveline Trachsel
Gilla Lättig-Tünnemann
Güliz Acker
Irina Kremenetskaia
Janet Lips
P2860
P304
27760-27772
P356
10.18632/ONCOTARGET.25570
P407
P577
2018-06-12T00:00:00Z